Esperion Therapeutics, Inc. - Common Stock (ESPR)
Seasonality Analysis
Esperion Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Esperion Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | -5.07% | Weak | |
| February | 9.08% | Weak | |
| March WORST | -5.85% | Very Weak | |
| April | -3.78% | Very Weak | |
| May | -3.50% | Weak | |
| June | 2.85% | Strong | |
| July | -1.52% | Very Weak | |
| August | 2.45% | Weak | |
| September | -0.90% | Weak | |
| October | -1.97% | Weak | |
| November BEST | 12.46% | Strong | |
| December | 4.89% | Weak |
Esperion Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Esperion Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Esperion Therapeutics, Inc. - Common Stock Pattern Scanner
Esperion Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Esperion Therapeutics, Inc. - Common Stock (ESPR) Seasonality
Esperion Therapeutics, Inc. - Common Stock (ESPR) has been analyzed using 13 years of historical data to identify seasonal patterns. Classified under Stocks, Esperion Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Esperion Therapeutics, Inc. - Common Stock is historically November, with an average return of 12.46% and a win rate of 69%. Conversely, March tends to be the weakest month, averaging -5.85% return.
Looking at the full calendar year, Esperion Therapeutics, Inc. - Common Stock has an average annual return of 9.15% with an overall monthly win rate of 45.8%. Out of 12 months, 5 typically show positive average returns.
The seasonal pattern for Esperion Therapeutics, Inc. - Common Stock has a consistency score of 30.5 (Poor), based on 14 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Esperion Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Esperion Therapeutics, Inc. - Common Stock (ESPR)?
Historically, November has been the best month for Esperion Therapeutics, Inc. - Common Stock, with an average return of 12.46% and a win rate of 69%. However, past performance does not guarantee future results.
What is the worst month for Esperion Therapeutics, Inc. - Common Stock (ESPR)?
Based on historical data, March has been the weakest month for Esperion Therapeutics, Inc. - Common Stock, with an average return of -5.85%. This is a historical observation and does not guarantee future results.
How reliable is ESPR seasonality data?
The seasonality analysis for Esperion Therapeutics, Inc. - Common Stock is based on 13 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Esperion Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Esperion Therapeutics, Inc. - Common Stock (ESPR) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.